The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
Courts

Federal Court Urged to Reverse FDA Approval of Abortion Pill

Federal Court Urged to Reverse FDA Approval of Abortion Pill
Food and Drug Administration (FDA) headquarters in White Oak, Md., on Aug. 29, 2020. Andrew Kelly/Reuters
Matthew Vadum
Matthew Vadum
2/12/2023|Updated: 2/12/2023
0:00

A group of national medical associations and doctors urged a federal court on Feb. 10 to order a federal regulator to reverse its two-decade-old approval of Mifepristone, a drug used for medication abortions that critics say endangers women who use it.

The abortion pill has become a focus of legal efforts by the pro-life movement since the Supreme Court overturned the 49-year-old Roe v. Wade precedent in June 2022, returning the regulation of abortion to the states, several of which have since banned or restricted abortions.

Matthew Vadum
Matthew Vadum
Author
Matthew Vadum is an award-winning investigative journalist.
Author’s Selected Articles

Supreme Court Allows Trump Admin to Revoke DEI-Related NIH Grants

Aug 21, 2025
Supreme Court Allows Trump Admin to Revoke DEI-Related NIH Grants

Appeals Court Strikes Down Part of Maryland Digital Advertising Tax

Aug 20, 2025
Appeals Court Strikes Down Part of Maryland Digital Advertising Tax

Appeals Court Rules DHS Can Revoke Temporary Status for Hondurans, Nicaraguans, and Nepalese

Aug 20, 2025
Appeals Court Rules DHS Can Revoke Temporary Status for Hondurans, Nicaraguans, and Nepalese

Appeals Court Won’t Invalidate Part of Voting Rights Act

Aug 19, 2025
Appeals Court Won’t Invalidate Part of Voting Rights Act
Related Topics
Texas
abortion pill
Add to My List
Save
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.